Variations of human killer cell lectin-like receptors: Common occurrence of NKG2-C deletion in the general population

Genes and Immunity

Volumn 4, Issue 2, 2003, Pages 160-167

  Hikami, K ^a   Tsuchiya, N ^a   Yabe, T ^b   Tokunaga, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPANESE RED CROSS SOCIETY   (Japan)

Author keywords

CD94; Deletion; NKG2; Polymorphism; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

AMINO ACID; CD94 ANTIGEN; CELL RECEPTOR; LECTIN RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2C; PHENYLALANINE; SERINE; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; IMMUNOGLOBULIN RECEPTOR; KLRD1 PROTEIN, HUMAN; LECTIN; LECTIN LIKE NK CELL RECEPTOR, HUMAN; LECTIN-LIKE NK CELL RECEPTOR, HUMAN; LEUKOCYTE ANTIGEN; NATURAL KILLER CELL ACTIVATING RECEPTORS;

5' UNTRANSLATED REGION; ADULT; AGED; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CHROMOSOME 12P; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC CONSERVATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CHROMOSOME; INTRON; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN POLYMORPHISM; REVIEW; RHEUMATOID ARTHRITIS; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; ARTICLE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

ADULT; ANTIGENS, CD; ANTIGENS, CD94; ARTHRITIS, RHEUMATOID; FEMALE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LECTINS, C-TYPE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC;

EID: 0347572662     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363940     Document Type: Review

References (46)

1. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989; 47: 187-376.
2. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999; 17: 189-220.
3. Lanier LL. NK cell receptors. Annu Rev Immunol 1998; 16: 359-393.
4. Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 2001; 19: 291-330.
5. Seaman WE. Natural killer cells and natural killer T cells. Arthritis Rheum 2000; 43: 1204-1217.
6. Chang C, Rodriguez A, Carretero M, Lopez-Botet M, Phillips JH, Lanier LL. Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol 1995; 25: 2433-2437.
7. Yabe T, McSherry C, Bach FH et al. A multigene family on human chromosome 12 encodes natural killer-cell lectins. Immunogenetics 1993; 37: 455-460.
8. Lazetic S, Chang C, Houchins P, Lanier LL, Phillips JH. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 1996; 157: 4741-4745.
9. Carretero M, Cantoni C, Bellon T et al. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur J Immunol 1997; 27: 563-567.
10. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 1998; 187: 813-818.
11. Lee N, Llano M, Carretero M et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 1998; 95: 5199-5204.
12. Braud VM, Allan DS, O'Callaghan CA et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998; 391: 795-799.
13. Houchins JP, Lanier LL, Niemi EC, Phillips JH, Ryan JC. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J Immunol 1997; 158: 3603-3609.
14. Plougastel B, Jones T, Trowsdale J. Genomic structure, chromosome location, and alternative splicing of the human NKG2A gene. Immunogenetics 1996; 44: 286-291.
15. Suto Y, Yabe T, Maenaka K, Tokunaga K, Tadokoro K, Juji T. The human natural killer gene complex (NKC) is located on chromosome 12p13.1-p13.2. Immunogenetics 1997; 46: 159-162.
16. Renedo M, Arce I, Rodriguez A et al. The human natural killer gene complex is located on chromosome 12p12-p13. Immunogenetics 1997; 46: 307-311.
17. Cornélis F, Faure S, Martinez M et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci USA 1998; 95: 10746-10750.
18. Moser KL, Neas BR, Salmon JE et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci USA 1998; 95: 14 869-14 874.
19. Plougastel B, Trowsdale J. Sequence analysis of a 62-kb region overlapping the human KLRC cluster of genes. Genomics 1998; 49: 193-199.
20. Renedo M, Arce I, Montgomery K et al. A sequence-ready physical map of the region containing the human natural killer gene complex on chromosome 12p12.3-p13.2. Genomics 2000; 65: 129-136.
21. Glienke J, Sobanov Y, Brostjan C et al. The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex. Immunogenetics 1998; 48: 163-173.
22. Brostjan C, Sobanov Y, Glienke J et al. The NKG2 natural killer cell receptor family: comparative analysis of promoter sequences. Genes Immun 2000; 1: 504-508.
23. Uhrberg M, Valiante NM, Shum BP et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997; 7: 753-763.
24. Trowsdale J. Genetic and functional relationships between MHC and NK receptor genes. Immunity 2001; 15: 363-374.
25. Shum BP, Flodin LR, Muir DG et al. Conservation and variation in human and common chimpanzee CD94 and NKG2 genes. J Immunol 2002; 168: 240-252.
26. Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000; 15: 7-12.
27. Sobanov Y, Glienke J, Brostjan C, Lehrach H, Francis F, Hofer E. Linkage of the NKG2 and CD94 receptor genes to D12S77 in the human natural killer gene complex. Immuogenetics 1999; 49: 99-105.
28. LaBonte ML, Hershberger KL, Korber B, Letvin NL. The KIR and CD94/NKG2 families of molecules in the rhesus monkey. Immunol Rev 2001; 183: 25-40.
29. Takei F, McQueen KL, Maeda M et al. Ly49 and CD94/NKG2: developmentally regulated expression and evolution. Immunol Rev 2001; 181: 90-103.
30. Vance RE, Jamieson AM, Cado D, Raulet DH. Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation. Proc Natl Acad Sci USA 2002; 99: 868-873.
31. Bohme J, Andersson M, Andersson G, Moller E, Peterson PA, Rask L. HLA-DR beta genes vary in number between different DR specificities, whereas the number of DQ beta genes is constant. J Immunol 1985; 135: 2149-2155.
32. Tokunaga K, Saueracker G, Kay PH, Christiansen FT, Anand R, Dawkins RL. Extensive deletions and insertions in different MHC supratypes detected by pulsed field gel electrophoresis. J Exp Med 1988; 168: 933-940.
33. Wagtmann N, Rojo S, Eichler E, Mohrenweiser H, Long EO. A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors. Curr Biol 1997; 7: 615-618.
34. Wende H, Colonna M, Ziegler A, Volz A. Organization of the leukocyte receptor cluster (LRC) on human chromosome 19q13.4. Mamm Genome 1999; 10: 154-160.
35. de Haas M, Kleijer M, van Zwieten R, Roos D, von dem Borne AE. Neutrophil Fcg RIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families. Blood 199; 86: 2403-2413.
36. Valiante NM, Uhrberg M, Shilling HG et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997; 7: 739-751.
37. Smith HR, Chuang HH, Wang LL, Salcedo M, Heusel JW, Yokoyama WM. Nonstochastic coexpression of activation receptors on murine natural killer cells. J Exp Med 2000; 191: 1341-1354.
38. Tomasec P, Braud VM, Rickards C et al. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 2000; 287: 1031.
39. Daniels KA, Devora G, Lai WC, O'Donnell CL, Bennett M, Welsh RM. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med 2001; 194: 29-44.
40. Lee SH, Girard S, Macina D et al. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet 2001; 28: 42-45.
41. Brown MG, Dokun AO, Heusel JW et al. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 2001; 292: 934-937.
42. Delano ML, Brownstein DG. Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype. J Virol 1995; 69: 5875-5877.
43. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
44. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
45. Tokunaga K, Imanishi T, Takahashi K, Juji T. On the origin and dispersal of East Asian populations as viewed from HLA haplotypes. In: Szathmary EJ (ed). Prehistoric Mongoloid Dispersals. Oxford University Press: Oxford, 1996, pp 187-197.
46. Hikami K, Tsuchiya N, Tokunaga K. New variations in human OX40 ligand (CD134L) gene. Genes Immun 2000; 1: 521-522.